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OBJECTIVE — The primary aim of the study was to investigate the relationship among
executive functioning, diabetes treatment adherence, and glycemic control.
RESEARCH DESIGN AND METHODS — Two hundred and thirty-ﬁve children with
type 1 diabetes and their primary caregivers were administered the Diabetes Self-Management
Proﬁle to assess treatment adherence. Executive functioning was measured using the Behavior
Rating Inventory of Executive Functioning and glycemic control was based on A1C.
RESULTS — Structural equation modeling indicated that a model in which treatment adher-
ence mediated the relationship between executive functioning and glycemic control best ﬁt the
data. All paths were signiﬁcant at P  0.01.
CONCLUSIONS — These results indicate that executive functioning skills (e.g., planning,
problem-solving, organization, and working memory) were related to adherence, which was
related to diabetes control. Executive functioning may be helpful to assess in ongoing clinical
management of type 1 diabetes.
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ype 1 diabetes is a prevalent chronic
condition that affects one in every
400–600 youth (1). Effective man-
agement of blood glucose levels has been
shown to reduce the risk for a wide range
of diabetes-related complications (1).
However, high rates of treatment nonad-
herence to the demanding type 1 diabetes
treatment regimen and less than optimal
glycemic control have been consistently
reported (2–5). Maintaining adequate
treatment adherence and glycemic con-
trol in type 1 diabetes requires the child
and family to organize several critical
daily management tasks including exer-
cise, dietary intake, blood glucose moni-
toring, and insulin administration,
especially related to carbohydrate intake.
Effective completion of these complex
tasks requires a range of cognitive skills
including organization, planning, prob-
lem solving, working memory, and be-
havioral self-regulation (6) that
encompassthebroadcognitivedomainof
executive functioning (7).
The child’s overall level of compe-
tence in executive functioning (e.g., abil-
ity to set goals and organize tasks and
ﬂexibility to adapt to treatment regimens)
may be an important inﬂuence on adher-
ence to treatment in type 1 diabetes and
potentially on glycemic control. How-
ever, the relationship among executive
functioning, treatment adherence, and
glycemic control in pediatric type 1 dia-
betes is not well understood. To our
knowledge, only one published study by
Bagner et al. (6) has addressed this issue
by demonstrating an association between
executivefunctioning,asmeasuredbythe
Behavior Rating Inventory of Executive
Functioning (BRIEF) (7), and treatment
adherence in a sample of youth with type
1 diabetes.
However, this study was limited by a
number of relevant methodological prob-
lems that were addressed in the present
study. Bagner et al. (6) studied a very
broad age range of participants (ages
8–19), did not test alternative models of
the relationship between executive func-
tioning and treatment adherence, and did
not include a measure of glycemic con-
trol. Age-related differences in executive
functioning were not controlled. More-
over, the fact that only one model of asso-
ciation between level of executive
functioning and treatment adherence was
tested limited the validity of inferences
thatcouldbedrawn.Forexample,Bagner
etal.(6)suggestedthattheirﬁndingssup-
ported the hypothesis that greater execu-
tive functioning facilitates adherence. On
the other hand, it is also possible that ad-
herence, especially problematic adher-
ence, may lead to poor glycemic control,
which, in turn, may have a negative im-
pact on memory and executive function-
ing (8,9). Because these alternative
pathways of inﬂuence have very different
implicationsfortargetinginterventions,it
is important to compare them. Finally,
Bagner et al. (6) did not describe the rela-
tionship of executive functioning and ad-
herence to glycemic control. For this
reason,theclinicalrelevanceoftheirﬁnd-
ings was limited.
To address the above methodological
problems,thepresentstudywasdesigned
toadvancescientiﬁcknowledgeinthefol-
lowing ways: 1) studying a larger sample
and more homogeneous age-group of
children(ages9–11)withtype1diabetes;
2) including a measure of glycemic con-
trol; and 3) testing alternative models of
the relationship among executive func-
tioning, treatment adherence, and glyce-
mic control. Our ﬁrst hypothesis was that
higherexecutivefunctioningwouldbeas-
sociated with better treatment adherence,
which in turn would relate to better gly-
cemic control. Our second hypothesis
was that the relationship between execu-
tive functioning and glycemic control
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by) treatment adherence.
RESEARCH DESIGN AND
METHODS— Participants were 235
children with type 1 diabetes and their
caregivers who were followed at pediatric
diabetes clinics at three university-
afﬁliatedmedicalcentersintheU.S.Insti-
tutional review boards at each site
approved the study. Data were collected
as part of an ongoing, 3-year longitudinal
study with the aim of investigating hy-
pothesized psychological processes in-
cluding parental support and changes in
allocation of treatment responsibility that
maypromotetreatmentadherenceduring
early adolescence in type 1 diabetes. For
the purpose of the present analysis, only
baseline data were considered. No prior
results from this study have been re-
ported.
Caregivers and children were re-
cruited during a regularly scheduled out-
patient clinic visit. Inclusion criteria
included diagnosis of type 1 diabetes for
at least 1 year, ages 9–11, absence of po-
tentialsecondarycausesoftype1diabetes
diagnosis (e.g., glucocorticoid treatment
or cystic ﬁbrosis), English-speaking fam-
ily, and no known plans to move out of
theareawithinthenext3years.Exclusion
criteria included current involvement in
foster care, the presence of severe psychi-
atric disorders or comorbid chronic con-
ditions (e.g., renal disease) that required
burdensome ongoing treatment regi-
mens, or diagnosis of mental retardation.
Eligible participants were identiﬁed
and contacted by clinic personnel to ask
about their interest in the study and then
were approached by research staff who
explained the study procedures. Of the
361 eligible participants who were ap-
proached, 240 (66.5%) consented and
participated.
As shown in Table 1, the sample in-
cluded 108 boys and 127 girls, ages 9.0–
12.1 (mean  SD 10.54  0.95) (4
childrenwererecruitedatage11butwere
not seen for baseline visits until after they
turned 12 years of age). On average, par-
ticipants had diabetes for 4.39  2.46
years(range1–11years).Basedonparen-
tal report, three children experienced a
severehypoglycemicepisode,resultingin
seizures or loss of consciousness in the
past 3 months.
Reasons for not participating in-
cluded being too busy (n  54), having
no transportation (n  3), and other (n 
64). Signed informed consent was ob-
tained from a parent or legal guardian,
and written assent was obtained from 11-
year-old children. Five parents did not




was measured using the BRIEF, an 86-
item parent report measure that assesses
children’s executive functioning (e.g.,
goal setting, organization, working mem-
ory, and so on) (7). The BRIEF includes
3-pointLikertscaleitemsthatindicatethe
extenttowhichthechild’sbehaviornever
occurred, sometimes occurred, or oc-
curred often. The range of possible com-
posite raw total scores is 72 to 216; and
therangeofpossiblecompositeTscoresis
30 to 100. For this sample, the range
of composite raw total scores was 74 to
198, and the range of composite T scores
was 31.92 to 82.33.
Reliability of the BRIEF has been es-
tablished (0.80–0.98) for both clin-
ical and normative samples (parent and
teacher forms) (7), and validity has been
documented with other measures of be-
havioral and attentional functioning (7).
In our sample, internal consistency was
0.98. The composite raw score for the
Global Executive Composite (GEC),
which is a summed score of all subscales,
was used in all analyses. The GEC com-
posite raw score and the standardized
GEC T score were virtually identical (r 
0.99). Raw scores were used in the pri-
mary statistical analyses.
Diabetes Self-Management Proﬁle.
The Diabetes Self-Management Proﬁle
(DSMP)isa25-itemstructuredinterview,
which was administered to assess diabe-
tes-related adherence behaviors during
the previous 3 months (11). Questions
wereaskedinanopen-endedmannerand
addressed the following domains: insulin
administration, blood glucose monitor-
ing, exercise, diet, and hypoglycemia
management. A total score was calculated
by summing all items to yield an overall
adherence score. Higher scores reﬂected
better adherence. The DSMP comprises
both dichotomous items (yes or no) and
3- to 5-point Likert scale items that were
coded based on how the child or primary
caregiver responded to the open-ended
questions. The range of possible total
scores is 0 to 88. The range of total scores
for the primary caregiver in this sample
was 42 to 86, and the range of total scores
for the child respondents was 39 to 80.
The DSMP total score has demon-
strated good internal consistency (r 
0.76), moderate cross-informant validity
for both parent and child report (r 
0.26), and strong interrater agreement
(r  0.94) (11). This measure has also
demonstratedgoodpredictivevaliditybe-
tween parent- and child-reported adher-
ence and self-management behaviors and
glycemiccontrol(11).Inthepresentsam-
ple, internal consistency was 0.62 for the
parent DSMP and 0.59 for the child
version.
Children and parents were inter-
viewed separately by trained research
staff. All research assistants had at least a
bachelor’s degree. Several had master’s
degrees, and one had a Ph.D. Training in-
cluded a general meeting of investigators
and site-speciﬁc training that included
reading the procedure manual for the
DSMP, practicing with another research
assistant, observing an experienced re-
search assistant conduct DSMPs, being
observed while conducting DSMPs, and
then conducting DSMPs independently.
Additional quality control procedures in-
volved review of data forms at the central
site and troubleshooting problems in ad-
ministration by the study coordinator at
the central site and research assistants at
different sites.
Glycemic control. A1C provided an es-
timate of metabolic control over the pre-
vious 2–3 months. Blood samples were
obtained by a ﬁngerstick during the visit,
and samples from each study site were
shippedtoonecentrallaboratoryforstan-
dardization purposes. Samples were ana-




All variables were approximately nor-
mally distributed, with the exception of
A1C,whichwassigniﬁcantlyskewed.For
this reason, a log transformation was per-
formed for this measure, and all subse-
quent analyses were conducted on the
transformed variable. Average SD A1C
for the sample was 8.16  1.33 (range
5.7–16.8). The American Diabetes Asso-
ciation recommends an A1C of 8.0%
for patients aged 6–12 years (1). Thus,
the present sample demonstrated fair gly-
cemic control.
FortheBRIEF,theaverageSDGEC
raw score was 118.98  27.55. The aver-
age sex- and age- corrected GEC T score
(mean  SD 52.12  11.17) was in the
normal range of functioning. For the
Executive functioning and glycemic control
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entreport(65.168.48)washigherthan
child reported adherence (60.86  8.10;




1 (models A and B). In testing model A,
bivariate analyses indicated no associa-
tion between glycemic control and exec-
utive functioning. For this reason, this
model did not ﬁt the data, indicating that
glycemic control did not mediate the re-
lationship between adherence and execu-
tive functioning.
In testing model B, bivariate analyses
indicatedsigniﬁcantcorrelationsbetween
executive functioning with adherence
(r  0.27, P  0.001) and between ad-
herence and glycemic control (r  0.33,
P0.001).Structuralequationmodeling
(SEM) was then used to test the adequacy
ofthestatisticalﬁtofmodelB.Advantages
of SEM include speciﬁc estimation of er-
ror terms and availability of a method to
determine the statistical adequacy of
model ﬁt (11). In the SEM analysis, the
measurement model that included the
DSMP parent and child reports as indica-
tors for the latent variable of adherence
was tested using AMOS (version 17).
Fit indexes were used to assess model
ﬁt. An acceptable ﬁt was deﬁned as fol-
lows: if the likelihood ratio 
2 test of
model ﬁt was nonsigniﬁcant. Both the
comparative ﬁt index (CFI) and the
Bentler and Bonnett Normed Fit Index
(NFI) were 0.90, and the root mean
square error of approximation (RMSEA)
was 0.08 (12). Using these criteria, all
indexes indicated adequate ﬁt for the
overall measurement model (likelihood
ratio
2[df2]5.34,P0.07;CFI
0.96; NFI  0.94; RMSEA  0.08). The
structural model (i.e., treatment adher-
ence mediating the relationship between
executive functioning and glycemic con-
trol) was then tested. Figure 2 shows the
standardized path coefﬁcients. The re-
sults indicated that all paths were signiﬁ-
cant at P  0.01. Examination of the ﬁt
indexes showed that the overall ﬁt of the
model was good; all ﬁt indexes surpassed
the threshold for adequate ﬁt (likelihood
ratio
2[df2]4.04,P0.13;CFI
0.97; NFI  0.96; RMSEA  0.07). Ex-
amination of modiﬁcation indexes re-
vealed that adding no other paths
improved model ﬁt.
CONCLUSIONS— The primary
ﬁndings of the present study were the fol-
lowing:1)thelevelofthechild’sexecutive
functioning was associated with treat-
ment adherence and self-management
such that high levels of executive func-
tioning related to better adherence; 2) the
child’s adherence to the diabetes treat-
ment regimen related to glycemic control
such that better control was associated
with better adherence; and 3) the child’s
glycemic control depended on (i.e., was
mediated by) treatment adherence. To
our knowledge, this is the ﬁrst empirical
demonstration of the interrelationships
among executive functioning, treatment
adherence,andglycemiccontrolinasam-
ple of children with type 1 diabetes.
These ﬁndings underscore the poten-
tial importance of individual differences
in executive functioning (e.g., goal set-
ting, behavioral regulation, and working
memory) in promoting adherence and
glycemic control in children with type 1
diabetes. Children with competencies in
executive functioning were more likely to
demonstrate better adherence in their di-
abetes regimen, which in turn related to
glycemic control.
Several issues, including sample se-
lection and generalizability, should be
considered in interpreting our ﬁndings.
The generalizability of the ﬁndings is lim-
itedbythefactthatthissampleincludeda
majority of Caucasian patients who were
also not at high risk for deﬁcits in execu-
tive functioning based on their age at di-
agnosis or frequency of hypoglycemic
episodes (8,9). For this reason, it is pos-
sible that the ﬁndings would have been
even more powerful in a sample of chil-
drenandadolescentswithtype1diabetes
with a broader range of ethnic diversity,
educational levels, and executive func-
tioning competence.
Futurestudieswillbenecessarytode-
termine whether our ﬁndings generalize
to a more diverse sample of families, chil-
dren with higher rates of hypoglycemia,
or older adolescents who might be ex-
pected to demonstrate greater problems
in executive functioning (12). Executive
functioning competence might be ex-
pected to have a stronger relationship to
adherence in older adolescents who have
greaterlevelsofresponsibilityfordiabetes
management than the younger children
who participated in this study. On the
other hand, parental executive function-
ing may be especially inﬂuential in the
management of younger (preschool and
school-aged) children with type 1 diabe-
tes and should be studied in future
research.
Figure 1—Hypothesized alternative models of the relationship between executive functioning,
treatment adherence, and glycemic control. A: Glycemic control mediating the relationship be-
tween adherence and executive functioning. B: Adherence mediates the relationship between ex-
ecutive functioning and glycemic control.
Figure 2—Structural model with treatment
adherence mediating the relationship between
executive functioning and glycemic control.
Standardized path coefﬁcients are shown.
DSMP-P, Diabetes Self-Management Proﬁle,
parent interview; DSMP-C, Diabetes Self-
Management Proﬁle, child interview. **P 
0.01.
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we cannot conclude that executive func-
tioning inﬂuenced adherence or that ad-
herence inﬂuenced control. Moreover,
our study described the relationship of
executive functioning competence to ad-
herence and glycemic control rather than
the relationship of clinically signiﬁcant
deﬁcits in executive functioning to non-
adherence or glycemic control. It is also
possible that the relationships among ex-
ecutive functioning, adherence, and con-
trol may differ in clinically relevant
subgroups of patients (e.g., those with
very poor versus those with good con-
trol). For this reason, the direction of ef-
fects found here and our inferences
concerning causal inﬂuence will be tested
in our ongoing prospective study. It
would also be informative to study the
potential impact of executive functioning
onchildren’scompetenceinmanagingin-
formation from new technologies such as
continuous blood glucose monitoring.
Our ﬁndings have several relevant
potential clinical implications. For exam-
ple,theysuggestthatmeasuringexecutive
functioning competence in ongoing man-
agementoftype1diabetesmaybehelpful
in understanding protective factors asso-
ciated with better diabetes management
and adherence. On the other hand, chil-
dren with clinically signiﬁcant deﬁcits in
executive functioning may also beneﬁt
from interventions that focus on provid-
ing family support to improve their orga-
nizational, planning, and problem-
solving skills (13).
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Table 1—Demographic characteristics of participants
%( n) Mean  SD
Child age (years) — 10.5  1.0




Relationship of primary caregiver
Biological mother 94.9 (223)
Biological father 2.6 (6)
Other 2.6 (6)
Child ethnicity
Non-Hispanic, Caucasian 76.2 (179)
Non-Hispanic, African American 4.3 (10)
Non-Hispanic, other 6.8 (16)
Hispanic, Caucasian 10.6 (25)
Hispanic, other 2.1 (5)
Primary caregiver education (years) — 14.5  2.3
Duration of diabetes (years) — 4.4  2.4
Insulin regimen
Insulin pump 56.2 (132)
Multiple daily injections 43.8 (103)
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